Medicare Enrolled
Dr. Gregory Cali, D.O.
Pulmonary Disease · Dunmore, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cali
Dr. Gregory Cali is a pulmonary disease specialist in Dunmore, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Cali performed 1,800 Medicare services across 1,522 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cali received a total of $6,535 from 32 pharmaceutical and/or device companies across 311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 12% volume in PA
$6,535 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,800
Medicare services
Top 12% in PA for pulmonary disease
1,522
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
527 | $85 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $63 | $115 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
108 | $27 | $111 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $110 | $210 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
92 | $40 | $90 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
76 | $19 | $72 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
46 | $29 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
45 | $77 | $140 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
42 | $72 | $90 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
39 | $91 | $325 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
37 | $67 | $130 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
37 | $68 | $250 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
35 | $29 | $40 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
34 | $89 | $325 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
32 | $14 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $119 | $185 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
26 | $49 | $100 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
17 | $122 | $125 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
13 | $13 | $52 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
11 | $282 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,535
Total received (2018-2024)
Avg $934/year across 7 years
Top 26% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,216 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$195 (3.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$125 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,105
2023
$486
2022
$619
2021
$347
2020
$581
2019
$1,550
2018
$1,846
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$236
GENZYME CORPORATION
$197
GlaxoSmithKline, LLC.
$148
Boehringer Ingelheim Pharmaceuticals, Inc.
$112
SANOFI-AVENTIS U.S. LLC
$80
Philips North America LLC
$62
Takeda Pharmaceuticals U.S.A., Inc.
$53
Merck Sharp & Dohme LLC
$45
Axsome Therapeutics, Inc.
$45
Actelion Pharmaceuticals US, Inc.
$35
CSL Behring
$29
Paratek Pharmaceuticals, Inc.
$18
Amgen Inc.
$17
Vifor Pharma, Inc.
$15
PFIZER INC.
$14
Top 3 companies account for 52.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,448
GlaxoSmithKline, LLC.
$1,344
Boehringer Ingelheim Pharmaceuticals, Inc.
$545
Grifols USA, LLC
$486
Genentech USA, Inc.
$360
Actelion Pharmaceuticals US, Inc.
$252
GENZYME CORPORATION
$241
United Therapeutics Corporation
$205
Novartis Pharmaceuticals Corporation
$169
Circassia Pharmaceuticals Inc
$157
Takeda Pharmaceuticals U.S.A., Inc.
$149
Bayer HealthCare Pharmaceuticals Inc.
$141
SANOFI-AVENTIS U.S. LLC
$138
Intuitive Surgical, Inc.
$128
CSL Behring
$113
Regeneron Healthcare Solutions, Inc.
$105
Philips Electronics North America Corporation
$96
Philips North America LLC
$62
Bayer Healthcare Pharmaceuticals Inc.
$48
Merck Sharp & Dohme LLC
$45
Axsome Therapeutics, Inc.
$45
Sunovion Pharmaceuticals Inc.
$37
Shire North American Group Inc
$34
Mallinckrodt Enterprises LLC
$32
PFIZER INC.
$30
Advanced Respiratory, Inc
$23
Mylan Specialty L.P.
$22
Paratek Pharmaceuticals, Inc.
$18
Janssen Biotech, Inc.
$18
Amgen Inc.
$17
Vifor Pharma, Inc.
$15
JAZZ PHARMACEUTICALS INC.
$13
Top 3 companies account for 51.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · CUVITRU · DUPIXENT · Da Vinci Surgical System · Esbriet · FASENRA · GLASSIA · Hizentra · KEYTRUDA · LONHALA MAGNAIR · LUMIZYME · NIOX VERO · NIOX VERO DEVICE · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PAXLOVID · PREVNAR 20 · Perforomist · Prolastin-C · Prolastin-C Liquid · SIMPONI · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · XOLAIR · XYREM · Xembify · Xolair · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
13
Per 100K population
6.0
County median income
$64,691
Nearest hospital
GEISINGER-COMMUNITY MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cali is a clinical cardiology specialist, with above-average Medicare volume (top 12% in PA), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cali performed 527 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cali receive payments from pharmaceutical companies?
Yes. Dr. Cali received a total of $6,535 from 32 companies across 311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cali's costs compare to other pulmonary diseases in Dunmore?
Dr. Cali's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Dunmore
Browse pulmonary diseases in Dunmore ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology